IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Premature Ejaculation
Interventions
DRUG

IX-01

DRUG

Placebo

Trial Locations (10)

2065

Australian Centre for Sexual Health, Saint Leonards

6009

Keogh Institute for Medical Research, Nedlands

10016

Manhattan Medical Research, New York

19004

Urologic Consultants of Southeastern Pennsylvania, Bala-Cynwyd

33180

South Florida Medical Research Inc., Aventura

33401

Center for Marital and Sexual Health of South Florida, West Palm Beach

70112

Tulane University School of Medicine, New Orleans

92120

San Diego Sexual Medicine, San Diego

08103

Cooper Research Institute, Camden

02906

Miriam Hospital / The Men's Health Center, Providence

All Listed Sponsors
collaborator

Carelon Research

OTHER

collaborator

Novotech (Australia) Pty Limited

INDUSTRY

collaborator

ICON plc

INDUSTRY

collaborator

PHT Corporation

INDUSTRY

lead

Ixchelsis Limited

INDUSTRY